Backend Engineer, Temporal
Abridge$185,000 - $265,000/year
- Full Time
- Mid-level (3 to 4 years)
About Abridge
Abridge provides a platform that changes how medical conversations are documented in healthcare settings. Its main product allows healthcare providers to record patient visits, which are then transformed into organized clinical documents. This helps doctors and other healthcare professionals save time on paperwork, allowing them to concentrate more on caring for their patients. Abridge stands out from its competitors by focusing specifically on the needs of healthcare providers, payers, and pharmaceutical companies, offering a solution that improves both documentation efficiency and patient outcomes. The goal of Abridge is to enhance the quality of patient care while making the documentation process easier for healthcare professionals.
Pittsburgh, PennsylvaniaHeadquarters
2018Year Founded
$201.8MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
51-200Employees
Benefits
Medical insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Equity
Flexible Spending (FSA) & Health Savings (HSA) Accounts
Learning and Development budget
401k Plan
Paid Parental Leave
Flexible working hours
Home Office Budget
Sabbatical Leave
Risks
Rapid expansion may strain Abridge's resources and affect service quality.
Integration challenges with EHR systems could disrupt workflows and data consistency.
Data privacy concerns in AI applications may lead to regulatory scrutiny.
Differentiation
Abridge transforms medical conversations into actionable clinical documentation using AI.
The platform supports over 28 languages and 50+ medical specialties.
Abridge's integration with EMR systems enhances clinician efficiency and patient care.
Upsides
Abridge's partnership with Mayo Clinic expands its reach to over 1 million patients.
The $150 million Series C funding accelerates AI technology development and integration.
Abridge's multilingual capabilities improve communication in diverse patient populations.
Funding
Total raised$201.84 M
Latest valuation$850.00 M
StageSERIES_C
SERIES B
9/30/2023$30
$150.00 M